2022 AIM-HI Women’s Venture Competition Announced 6 Semi-Finalists!
The AIM-HI Accelerator Fund (AIM-HI) just announced 6 Semi-Finalists for the [...]
The AIM-HI Accelerator Fund (AIM-HI) just announced 6 Semi-Finalists for the [...]
On March 31, 2022, the clinical trial application of ARB202 [...]
The year 2021 saw an unprecedented triumph of science as [...]
We have great news to share! The 2022 AIM-HI Women’s Venture Competition is [...]
The AIM-HI Accelerator Fund is fiercely dedicated to accelerating the commercialization [...]
The AIM-HI Accelerator Fund just announced 10 semi-finalists for the [...]
Tvardi Therapeutics, Inc. (“Tvardi”) a privately held, clinical-stage biopharmaceutical company [...]
Are you struggling to increase clinical trial awareness, recruitment, and [...]
Privo Technologies, Inc. (“Privo”), a biopharmaceutical company focused on optimizing state-of-the-art [...]
Closes $5 million Series A financing Appoints Pritesh J. Gandhi, [...]